AI & Machine Learning

RBC's mid-year outlook reveals a resilient bull market powered by stellar earnings, but warns of historical volatility as yields and election risks loom.

A new strategic partnership aims to overcome drug resistance in GI cancers by combining Lonza's advanced ADC platform with Antharis's targeted antibody expertise.

At Automate 2026, Taiwan isn't just selling robots. It's offering a strategic partnership to rebuild U.S. manufacturing with its advanced AI and automation.

With Intel's new Panther Lake chips, ARBOR Technology is moving AI model training from the cloud to the device, promising a new era of truly adaptive automation.

As autonomous AI agents begin to dominate internet traffic, a new cybersecurity battleground is emerging. We explore the shift to agent trust management.

BetterAge's new executive team signals a potent strategy: combining deep industry partnerships with advanced AI to scale in the competitive elder care market.

Whimstay's new feature lets you book a vacation home hours before check-in, challenging hotels and solving the industry's spontaneity problem.

At VivaTech 2026, JCDecaux unveiled a bus shelter that fights heatwaves and AI-driven ads, blurring the line between public service and modern commerce.

As AI's hunger for processing power outstrips supply, a new class of specialized cloud providers is emerging to challenge the giants. But can they deliver?

As biopharma navigates a maze of privacy laws and AI, a new platform aims to centralize patient consent, turning a compliance nightmare into a bridge for trust.

As AI promises to revolutionize medicine, enterprises face complex challenges. A new ISG study aims to chart the critical partner ecosystem.

Immuta's expanded Databricks partnership introduces a new security paradigm for autonomous AI, promising to turn a critical risk into a commercial advantage.

A defense tech investor's bet on a Databricks partner reveals a crucial truth: the AI revolution will be built not by algorithms alone, but by modernizing data.

As AI-powered cyberattacks escalate, Lumos has launched its 'Identity Agent Force,' an autonomous team of AI agents designed to defend the enterprise.

As AI drug discovery faces a crucial test, Terray Therapeutics hires a proven dealmaker. Can Lisa Decker translate digital promise into clinical reality?

Anchorage Digital's custody of tokenized CETES marks a milestone, creating a federally regulated blueprint for bringing real-world sovereign debt onto the blockchain.

The online therapy market is booming, attracting institutional capital. We dissect the growth drivers, regulatory risks, and evolving business models.

Big Pharma is pouring over $1 billion into AI to design complex drugs, trading lab guesswork for algorithms. It's a high-stakes play to fix a broken R&D model.

New data reveals a startling truth: confusing parking payments aren't just annoying—they're costing local businesses and reshaping how we live in our cities.

With a new $75M fund, Gutter Capital is doubling down on its 'old school' model: intense operational support for 'overlooked' founders in New York City.